The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer

被引：340
|
作者：
Liu, Tao [1 ]
Liu, Pei Y. [1 ]
Marshall, Glenn M. [1 ,2 ]
机构：
[1] Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia
[2] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2009年 / 69卷 / 05期
基金：
英国医学研究理事会;
关键词：
REGULATES SIRT1; P53; MOUSE;
D O I：
10.1158/0008-5472.CAN-08-3365
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gene expression and deacetylase activity of the class III histone deacetylase SIRT1 are up-regulated in cancer cells due to oncogene overexpression or loss of function of tumor suppressor genes. SIRT1 induces histone deacetylation and methylation, promoter CpG island methylation, transcriptional repression, and deacetylation of tumor suppressor proteins. SIRT1 may play a critical role in tumor initiation, progression, and drug resistance by blocking senescence and apoptosis, and promoting cell growth and angiogenesis. SIRT1 inhibitors have shown promising anticancer effects in animal models of cancer. Further screening for more potent SIRT1 inhibitors may lead to compounds suitable for clinical trials in patients. [Cancer Res 2009;69(5):1702-5]
引用
收藏
页码：1702 / 1705
页数：4
相关论文
共 50 条
  • [31] Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication
    Ling, Hongbo
    Peng, Lirong
    Wang, Jianbo
    Rahhal, Raneen
    Seto, Edward
    CELL REPORTS, 2018, 25 (10): : 2851 - +
  • [32] Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma
    Jang, Si-Hyong
    Min, Kyeung-Whan
    Paik, Seung Sam
    Jang, Ki-Seok
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (08) : 735 - 739
  • [33] The Histone Deacetylase SIRT1 Is Anti-Fibrotic and Mediates Resveratrol Effects.
    Marangoni, Roberta G.
    Ghosh, Archit
    Wei, Jun
    Varga, John
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S969 - S969
  • [34] A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
    Lee, In Hye
    Cao, Liu
    Mostoslavsky, Raul
    Lombard, David B.
    Liu, Jie
    Bruns, Nicholas E.
    Tsokos, Maria
    Alt, Frederick W.
    Finkel, Toren
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (09) : 3374 - 3379
  • [35] The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
    Firestein, Ron
    Blander, Gil
    Michan, Shaday
    Oberdoerffer, Philipp
    Ogino, Shuji
    Campbell, Jennifer
    Bhimavarapu, Anupama
    Luikenhuis, Sandra
    de Cabo, Rafael
    Fuchs, Charles
    Hahn, William C.
    Guarente, Leonard P.
    Sinclair, David A.
    PLOS ONE, 2008, 3 (04):
  • [36] Comparative and pharmacophore model for deacetylase SIRT1
    Huhtiniemi, Tero
    Wittekindt, Carsten
    Laitinen, Tuomo
    Leppanen, Jukka
    Salminen, Antero
    Poso, Antti
    Lahtela-Kakkonen, Maija
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (09) : 589 - 599
  • [37] Comparative and pharmacophore model for deacetylase SIRT1
    Tero Huhtiniemi
    Carsten Wittekindt
    Tuomo Laitinen
    Jukka Leppänen
    Antero Salminen
    Antti Poso
    Maija Lahtela-Kakkonen
    Journal of Computer-Aided Molecular Design, 2006, 20 : 589 - 599
  • [38] The Role of SIRT1 in Cancer The Saga Continues
    Wilking, Melissa J.
    Ahmad, Nihal
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (01): : 26 - 28
  • [39] Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation
    Chanda, Dipanjan
    Xie, Yuan-Bin
    Choi, Hueng-Sik
    NUCLEIC ACIDS RESEARCH, 2010, 38 (14) : 4607 - 4619
  • [40] Genetic and chemical knockdown of class III histone deacetylase (HDAC) Sirt1 decreases cellular growth and induces apoptosis in cutaneous T-cell lymphoma (CTCL)
    Nihal, M.
    Ahmad, N.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S23 - S23
12345